skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Experimental evaluation of the glucose antimetabolite, 2-deoxy-D-glucose (2-DG) as a possible adjuvant to radiotherapy of tumors: I. Kinetics of growth and survival of ehrlich ascites tumor cells (EATC) in vitro and of growth of solid tumors after 2-DG and x-irradiation

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
 [1];
  1. Gesellschaft fur Strahlen- und Umeltforschung mbH., Munchen, West Germany

Modifications of cell proliferation and survival induced by 2-DG and X-irradiation alone or in combination were studied under both aerobic and hypoxic conditions and for cells both in exponential and plateau phase. The degree of inhibition of cell proliferation was found to be dependent on absorbed dose of X rays and on the 2-DG/Glucose Molar ratio in the medium. At an equimolar ratio (2-DG/Glucose = 1) in nutrient medium the growth of euoxic EATC was ihibited by 80% relative to the control (without 2-DG). This inhibition was fully reversible up to 48 hours of the culture inoculation if 2-DG was removed from the medium, demonstrating the importance of glucose and glycolysis for tumor growth. The inhibitory effects of 2-DG on the viability of cultured cells when applied alone or in combination with radiation was found to be more pronounced in hypoxic cells than in euoxic cells. The combined effect of both noxae (2-DG and X-irradiation) on the growth inhibition of euoxic EATC in cultures was slightly more than additive, while they were clearly snyergistic on the growth inhibition of solid tumors in vivo. As tumors are known to have a fraction of hypoxic cells, it seems likely that synergistic action of 2-DG results from the stronger effect of 2-DG on these cells. The reason for the stronger effect may be a result of inhibition of their glycolytic energy supply limiting repair processes. Our results suggest that 2-DG could be used to advantage as an adjuvant in radiotherapy of human tumors.

OSTI ID:
6704165
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 8:3/4
Country of Publication:
United States
Language:
English

Similar Records

Glycolytic inhibitor 2-Deoxy-d-Glucose activates migration and invasion in glioblastoma cells through modulation of the miR-7-5p/TFF3 signaling pathway
Journal Article · Tue May 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:6704165

Enhanced Response of Human Head and Neck Cancer Xenograft Tumors to Cisplatin Combined With 2-Deoxy-D-Glucose Correlates With Increased {sup 18}F-FDG Uptake as Determined by PET Imaging
Journal Article · Thu Nov 15 00:00:00 EST 2007 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:6704165

Hyperthermia and radiation in vivo: effect of 2-deoxy-D-glucose
Journal Article · Fri Mar 01 00:00:00 EST 1985 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6704165